143 related articles for article (PubMed ID: 26776511)
1. let-7 Modulates Chromatin Configuration and Target Gene Repression through Regulation of the ARID3B Complex.
Liao TT; Hsu WH; Ho CH; Hwang WL; Lan HY; Lo T; Chang CC; Tai SK; Yang MH
Cell Rep; 2016 Jan; 14(3):520-533. PubMed ID: 26776511
[TBL] [Abstract][Full Text] [Related]
2. Distinct and overlapping roles of ARID3A and ARID3B in regulating E2F‑dependent transcription via direct binding to E2F target genes.
Saadat KASM; Lestari W; Pratama E; Ma T; Iseki S; Tatsumi M; Ikeda MA
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649863
[TBL] [Abstract][Full Text] [Related]
3. LIN28-
Ali A; Anthony RV; Bouma GJ; Winger QA
FASEB J; 2019 Nov; 33(11):12348-12363. PubMed ID: 31415216
[TBL] [Abstract][Full Text] [Related]
4. The Role of LIN28-
Ali A; Bouma GJ; Anthony RV; Winger QA
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455665
[TBL] [Abstract][Full Text] [Related]
5. ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells.
Dausinas P; Pulakanti K; Rao S; Cole JM; Dahl R; Cowden Dahl KD
Gene; 2020 May; 738():144458. PubMed ID: 32061921
[TBL] [Abstract][Full Text] [Related]
6. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC).
Nasuh S; Balci SO; Bozgeyik I; Ikeda MA; Tekayev M; Saadat KASM
Pathol Res Pract; 2023 Dec; 252():154948. PubMed ID: 37977034
[TBL] [Abstract][Full Text] [Related]
7. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer.
Liao TT; Lin CC; Jiang JK; Yang SH; Teng HW; Yang MH
Theranostics; 2020; 10(14):6095-6112. PubMed ID: 32483441
[No Abstract] [Full Text] [Related]
8. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
[TBL] [Abstract][Full Text] [Related]
9. ARID3B Directly Regulates Ovarian Cancer Promoting Genes.
Bobbs A; Gellerman K; Hallas WM; Joseph S; Yang C; Kurkewich J; Cowden Dahl KD
PLoS One; 2015; 10(6):e0131961. PubMed ID: 26121572
[TBL] [Abstract][Full Text] [Related]
10. Critical role of ARID3B in the expression of pro-apoptotic p53-target genes and apoptosis.
Pratama E; Tian X; Lestari W; Iseki S; Ichwan SJ; Ikeda MA
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):248-54. PubMed ID: 26519881
[TBL] [Abstract][Full Text] [Related]
11. Arid3b Is Critical for B Lymphocyte Development.
Kurkewich JL; Klopfenstein N; Hallas WM; Wood C; Sattler RA; Das C; Tucker H; Dahl R; Cowden Dahl KD
PLoS One; 2016; 11(8):e0161468. PubMed ID: 27537840
[TBL] [Abstract][Full Text] [Related]
12. ZEB1 induced miR-99b/let-7e/miR-125a cluster promotes invasion and metastasis in esophageal squamous cell carcinoma.
Ma J; Zhan Y; Xu Z; Li Y; Luo A; Ding F; Cao X; Chen H; Liu Z
Cancer Lett; 2017 Jul; 398():37-45. PubMed ID: 28408353
[TBL] [Abstract][Full Text] [Related]
13. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
[TBL] [Abstract][Full Text] [Related]
14. Folate Receptor Alpha Upregulates Oct4, Sox2 and Klf4 and Downregulates miR-138 and miR-let-7 in Cranial Neural Crest Cells.
Mohanty V; Shah A; Allender E; Siddiqui MR; Monick S; Ichi S; Mania-Farnell B; G McLone D; Tomita T; Mayanil CS
Stem Cells; 2016 Nov; 34(11):2721-2732. PubMed ID: 27300003
[TBL] [Abstract][Full Text] [Related]
15. ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death.
Joseph S; Deneke VE; Cowden Dahl KD
PLoS One; 2012; 7(7):e42159. PubMed ID: 22860069
[TBL] [Abstract][Full Text] [Related]
16. ARID3B expression in primary breast cancers and breast cancer-derived cell lines.
Oguz Erdogan AS; Ozdemirler N; Oyken M; Alper M; Erson-Bensan AE
Cell Oncol (Dordr); 2014 Aug; 37(4):289-96. PubMed ID: 25120063
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.
Yu CC; Chen YW; Chiou GY; Tsai LL; Huang PI; Chang CY; Tseng LM; Chiou SH; Yen SH; Chou MY; Chu PY; Lo WL
Oral Oncol; 2011 Mar; 47(3):202-10. PubMed ID: 21292542
[TBL] [Abstract][Full Text] [Related]
18. The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.
Cowden Dahl KD; Dahl R; Kruichak JN; Hudson LG
Neoplasia; 2009 Nov; 11(11):1208-15. PubMed ID: 19881956
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of ARID3B in normal adult tissue and carcinomas.
Samyesudhas SJ; Roy L; Cowden Dahl KD
Gene; 2014 Jun; 543(1):174-80. PubMed ID: 24704276
[TBL] [Abstract][Full Text] [Related]
20. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
Mitra D; Das PM; Huynh FC; Jones FE
J Biol Chem; 2011 Nov; 286(47):40531-5. PubMed ID: 21969366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
